Skip to the page

Data / Drug companies / Granule, for suspension

Companies that list granule, for suspension products: 23 companies and 35 products in the FDA NDC directory

The FDA National Drug Code Directory lists 35 products that are granule, for suspension products from 23 companies. The ten largest listers hold 60.0% of them, and the newest started marketing on July 7, 2025.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies
23
Products
35
Drugs by generic name
10
Main marketing category
New drug applications (NDA)

Companies that list granule, for suspension products

Ranked by number of products in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Ani Pharmaceuticals, Inc.3granule, for suspensionGeneric drugs (ANDA)March 25, 2019
Astellas Pharma Inc.2granule, for suspensionDrugs for further processingMay 24, 2018
Astellas Pharma US, Inc.2granule, for suspensionNew drug applications (NDA)May 24, 2018
Aurobindo Pharma Limited2granule, for suspensionGeneric drugs (ANDA)June 8, 2007
Azurity Pharmaceuticals, Inc.2granule, for suspensionNew drug applications (NDA)April 18, 2011
Cmic Cmo Co., LTD.2granule, for suspensionDrugs for further processingMay 24, 2018
Genentech, Inc.2granule, for suspensionNew drug applications (NDA)May 30, 2025
NorthStar Rx LLC2granule, for suspensionGeneric drugs (ANDA)June 8, 2007
Pharmacia & Upjohn Company LLC2granule, for suspensionNew drug applications (NDA)April 18, 2000
Rising Pharma Holdings, Inc.2granule, for suspensionGeneric drugs (ANDA)June 8, 2007
Wilshire Pharmaceuticals, Inc.2granule, for suspensionNew drug applications (NDA)September 28, 2016
American Health Packaging1granule, for suspensionGeneric drugs (ANDA)August 20, 2023
Ascend Laboratories, LLC1granule, for suspensionGeneric drugs (ANDA)July 7, 2025
Camber Pharmaceuticals, Inc.1granule, for suspensionGeneric drugs (ANDA)October 31, 2022
IntraBio Inc1granule, for suspensionNew drug applications (NDA)September 24, 2024
Janssen Pharmaceuticals, Inc.1granule, for suspensionNew drug applications (NDA)December 1, 2021
Merck Sharp & Dohme LLC1granule, for suspensionNew drug applications (NDA)February 18, 2020
Merck Sharp & Dohme LLC1granule, for suspensionNew drug applications (NDA)December 20, 2013
Mylan Pharmaceuticals Inc.1granule, for suspensionAuthorized generics (NDA)April 4, 1977
Patheon France S.a.s.1granule, for suspensionDrugs for further processingSeptember 24, 2024
Patheon Inc.1granule, for suspensionDrugs for further processingDecember 1, 2021
Patheon Pharmaceuticals Inc.1granule, for suspensionDrugs for further processingDecember 20, 2013
Shionogi Pharma Co., Ltd.1granule, for suspensionDrugs for further processingJuly 23, 2020

Drugs most often listed

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.